Vectura, which specializes in inhaled drug development solutions, has been granted planning permission for a new 10,000-square meter facility on Bristol & Bath Science Park, in southwest England, which will become the company’s Inhalation Center of Excellence. The state-of-the-art $62 million (£58mn) building, which is anticipated to be completed in 2025, will enable Vectura to expand its operations, while providing new career opportunities for research and development scientists and engi...